The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT01972672 · COMPLETED
Trial details
- NCT number
- NCT01972672
- Sponsor
- Beijing Shenogen Biomedical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-08-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.